Patent Assignment
Reel/Frame 021836/0868
Assignment of Assignor's Interest
Recorded: 2008-11-14
Pages: 4
Assignor
WANG, MING-BO
Executed: 2008-07-01
Assignee
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
LIMESTONE AVENUE, CAMPBELL ACT 2612, AUSTRALIA
Covered Properties
(2)
Glycan-Optimized Anti-CD20 Antibodies
Application:
12/115,133 →
Publication:
US 2009/0060921
Glycan-Optimized Anti-CD20 Antibodies
Application:
60/916,125 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 14, 2008
From: DICKEY, LYNN F.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021836/0826 →
Assignment of Assignor's Interest
Nov 14, 2008
From: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
To: BIOLEX, INC.
Reel/Frame 021836/0901 →
Change of Name
Nov 19, 2008
From: BIOLEX, INC.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021856/0582 →
Security Agreement
Nov 9, 2010
From: BIOLEX THERAPEUTICS, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 025333/0026 →
Release of Security Interest
May 21, 2012
From: MIDCAP FINANCIAL SBIC, LP
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 028276/0548 →
Assignment of Assignor's Interest
May 22, 2012
From: BIOLEX THERAPEUTICS, INC.
To: SYNTHON BIOPHARMACEUTICALS B.V.
Reel/Frame 028278/0729 →